Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery-Reference-Cited by-同舟云学术

Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery

Published:2021-12-11 Issue:2 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Tvedt Tor Henrik A.¹²^ORCID,Steien Egil³,Øvrebø Bente³,Haaverstad Rune⁴,Hobbs William⁵,Wardęcki Marek⁶^ORCID,Tjønnfjord Geir Erland²,Berentsen Sigbjørn Andreas⁷

Affiliation:

1. Department of Medicine Haukeland University Hospital Bergen Norway

2. Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B‐cell malignancies, Institute of Clinical Medicine University of Oslo Oslo Norway

3. Department of Anesthesia and Intensive Care Haukeland University Hospital Bergen Norway

4. Section of Cardiothoracic Surgery, Department of Heart Disease Haukeland University Hospital Bergen Norway

5. Sanofi Cambridge Massachusetts USA

6. Sanofi Warsaw Poland

7. Department of Research and Innovation Haugesund Hospital Haugesund Norway

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26409

Reference10 articles.

1. Clinical immunology of chronic cold agglutinin disease

2. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease

3. Acute Phase Haemolysis in Chronic Cold Agglutinin Disease

4. Cold agglutinin disease revisited: a multinational, observational study of 232 patients

5. Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms;Expert Review of Hematology;2024-06-28

2. Antibody based therapeutics for autoimmune hemolytic anemia;Expert Opinion on Biological Therapy;2023-11

3. Monoclonal antibodies for treatment of cold agglutinin disease;Expert Opinion on Biological Therapy;2023-05-04

4. Sutimlimab for the Treatment of Cold Agglutinin Disease;HemaSphere;2023-05

5. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?;Frontiers in Immunology;2023-04-24